Neurocontrol of movement: system identification approach for clinical benefit

C.G.M. Meskers, J.H. de Groot, E. de Vlugt, Alfred Christiaan Schouten

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
132 Downloads (Pure)


Progress in diagnosis and treatment of movement disorders after neurological diseases like stroke, cerebral palsy (CP), dystonia and at old age requires understanding of the altered capacity to adequately respond to physical obstacles in the environment. With posture and movement disorders, the control of muscles is hampered, resulting in aberrant force generation and improper impedance regulation. Understanding of this improper regulation not only requires the understanding of the role of the neural controller, but also attention for: (1) the interaction between the neural controller and the “plant”, comprising the biomechanical properties of the musculaskeletal system including the viscoelastic properties of the contractile (muscle) and non-contractile (connective) tissues: neuromechanics; and (2) the closed loop nature of neural controller and biomechanical system in which cause and effect interact and are hence difficult to separate. Properties of the neural controller and the biomechanical system need to be addressed synchronously by the combination of haptic robotics, (closed loop) system identification (SI), and neuro-mechanical modeling. In this paper, we argue that assessment of neuromechanics in response to well defined environmental conditions and tasks may provide for key parameters to understand posture and movement disorders in neurological diseases and for biomarkers to increase accuracy of prediction models for functional outcome and effects of intervention.
Original languageEnglish
Article number48
Pages (from-to)1-11
Number of pages11
JournalFrontiers in integrative neuroscience
Issue number48
Publication statusPublished - 2015


  • METIS-314053
  • IR-100840


Dive into the research topics of 'Neurocontrol of movement: system identification approach for clinical benefit'. Together they form a unique fingerprint.

Cite this